Quick Answer
Structure Therapeutics Inc. reported Net Income of -$141.20 million for fiscal year 2025.
Structure Therapeutics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$141.20M | -15.2% |
| 2024 | -$122.53M | -36.7% |
| 2023 | -$89.62M | -74.6% |
| 2022 | -$51.32M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$65.71M | -93.4% | -6.6% |
| June 30, 2025 | -$61.66M | -136.8% | -31.7% |
| March 31, 2025 | -$46.83M | -79.9% | -37.8% |
| September 30, 2024 | -$33.98M | -42.4% | -30.5% |
| June 30, 2024 | -$26.03M | -11.8% | +0.0% |
| March 31, 2024 | -$26.04M | -44.8% | -9.1% |
| September 30, 2023 | -$23.86M | -92.2% | -2.5% |
| June 30, 2023 | -$23.28M | -66.9% | -29.5% |
- Structure Therapeutics Inc. showed a decrease of -15.2% in Net Income compared to the prior fiscal year.
- Over the 2022–2025 period, Structure Therapeutics Inc.’s net income has declined by 175.1% (from -$51.32 million to -$141.20 million).
- The most recent figure is from Structure Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: